Eric M. Parker

7.4k total citations · 1 hit paper
94 papers, 4.6k citations indexed

About

Eric M. Parker is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Eric M. Parker has authored 94 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 41 papers in Cellular and Molecular Neuroscience and 29 papers in Physiology. Recurrent topics in Eric M. Parker's work include Receptor Mechanisms and Signaling (36 papers), Alzheimer's disease research and treatments (24 papers) and Neuropeptides and Animal Physiology (20 papers). Eric M. Parker is often cited by papers focused on Receptor Mechanisms and Signaling (36 papers), Alzheimer's disease research and treatments (24 papers) and Neuropeptides and Animal Physiology (20 papers). Eric M. Parker collaborates with scholars based in United States, United Kingdom and Germany. Eric M. Parker's co-authors include Elliott M. Ross, Luigi X. Cubeddu, Guy A. Higgins, Lili Zhang, Lawrence G. Iben, Lixin Song, Sui‐Lam Wong, Tsutomu Higashijima, Kimihiko Kameyama and Deborra Mullins and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Eric M. Parker

93 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chronic Treatment with the γ-Secretase Inhibitor LY-411,575 Inhibits β-Amyloid Peptide Production and Alters Lymphopoiesis and Intestinal Cell Differentiation

2004 583 citations Gwendolyn T. Wong, Frederique M. Poulet et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Eric M. Parker

Since Specialization

Citations

This map shows the geographic impact of Eric M. Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric M. Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric M. Parker more than expected).

Fields of papers citing papers by Eric M. Parker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric M. Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric M. Parker. The network helps show where Eric M. Parker may publish in the future.

Co-authorship network of co-authors of Eric M. Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Eric M. Parker. A scholar is included among the top collaborators of Eric M. Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric M. Parker. Eric M. Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of particle filtration efficiency of commercially available materials for homemade face mask usage 2021 ·Aerosol Science and Technology ·Taekyu Joo, Masayuki Takeuchi, Fobang Liu, Matthew P. Rivera, (unknown), E Blum, Eric M. Parker, (unknown), (unknown), (unknown), Ryan P. Lively, N. L. Ng	28
2	Design and discovery of C2-fluoroalkyl iminothiazine dioxides as BACE inhibitors 2021 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Wen‐Lian Wu, Jinsong Hao, (unknown), Hongwu Wang, Dorothy Levorse, Peter Orth, Lynn A. Hyde, (unknown), Maria S. Michener, Matthew Kennedy, Eric M. Parker, Jared N. Cumming	3
3	Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators 2017 ·ACS Medicinal Chemistry Letters ·Zhiqiang Zhao, Dmitri Pissarnitski, Xianhai Huang, Anandan Palani, Zhaoning Zhu, William J. Greenlee, Lynn A. Hyde, Lixin Song, Giuseppe Terracina, (unknown), Eric M. Parker	10
4	MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition 2015 ·Journal of Pharmacology and Experimental Therapeutics ·Matthew Fell, Christian Mirescu, Kallol Basu, Boonlert Cheewatrakoolpong, Duane E. DeMong, J. Michael Ellis, Lynn A. Hyde, Yinghui Lin, Carrie G. Markgraf, Hong Mei, Michael A. Miller, Frederique M. Poulet, Jack D. Scott, Michelle Smith, Zhizhang Yin, Xiaoping Zhou, Eric M. Parker, Matthew Kennedy, John A. Morrow	206
5	Use of molecular modeling aided design to dial out hERG liability in adenosine A2A receptor antagonists 2015 ·Bioorganic & Medicinal Chemistry Letters ·Qiaolin Deng, Yeon‐Hee Lim, Rajan Anand, Younong Yu, Jae‐Hun Kim, Wei Zhou, Junying Zheng, Paul Tempest, Dorothy Levorse, Xiaoping Zhang, Scott Greene, Deborra Mullins, Chris Culberson, Brad Sherborne, Eric M. Parker, Andrew W. Stamford, Amjad Ali	9
6	Novel orally active morpholine N-arylsulfonamides γ-secretase inhibitors with low CYP 3A4 liability 2009 ·Bioorganic & Medicinal Chemistry Letters ·Hubert Josien, Thomas Bara, (unknown), John W. Clader, William J. Greenlee, Leonard Favreau, Lynn A. Hyde, Amin A. Nomeir, Eric M. Parker, Lixin Song, (unknown), Qi Zhang	11
7	The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates 2008 ·Psychopharmacology ·Geoffrey B. Varty, Robert A. Hodgson, Annamarie J. Pond, (unknown), Eric M. Parker, John C. Hunter	40
8	Discovery of amide and heteroaryl isosteres as carbamate replacements in a series of orally active γ-secretase inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Mark D. McBriar, John W. Clader, Inhou Chu, Robert A. Del Vecchio, Leonard Favreau, William J. Greenlee, Lynn A. Hyde, Amin A. Nomeir, Eric M. Parker, Dmitri Pissarnitski, Lixin Song, Lili Zhang, Zhiqiang Zhao	37
9	Discovery of an orally efficaceous 4-phenoxypyrrolidine-based BACE-1 inhibitor 2007 ·Bioorganic & Medicinal Chemistry Letters ·Ulrich Iserloh, Jianping Pan, Andrew W. Stamford, Matthew Kennedy, (unknown), (unknown), Eric M. Parker, Nansie A. McHugh, Leonard Favreau, Corey Strickland, Johannes Voigt	49
10	Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice 2005 ·Behavioural Brain Research ·Lynn A. Hyde, Tatiana M. Kazdoba, Mariagrazia Grilli, Gianluca Lozza, (unknown), Qi Zhang, Gwendolyn T. Wong, (unknown), Lili Zhang, Eric M. Parker, Guy A. Higgins	68
11	Increased auditory startle response and reduced prepulse inhibition of startle in transgenic mice expressing a double mutant form of amyloid precursor protein 2003 ·Brain Research ·(unknown), Geoffrey B. Varty, Robert A. Del Vecchio, Tatiana M. Kazdoba, Eric M. Parker, John C. Hunter, Lynn A. Hyde	29
12	Activation of central melanocortin receptors by MT‐II increases cavernosal pressure in rabbits by the neuronal release of NO 2001 ·British Journal of Pharmacology ·(unknown), Stan Kurowski, Brian Salisbury, Eric M. Parker, Harry Davis	20
13	Pharmacological characterization of the cloned neuropeptide Y y6 receptor 2000 ·European Journal of Pharmacology ·Deborra Mullins, M. Guzzi, Ling Xia, Eric M. Parker	34
14	Molecular approaches to the discovery of new treatments for obesity 1997 ·Current Opinion in Chemical Biology ·Catherine D. Strader, D. Euan MacIntyre, Mari R. Candelore, Eric M. Parker	7
15	The binding of propranolol at 5-hydroxytryptamine1D beta T355N mutant receptors may involve formation of two hydrogen bonds to asparagine. 1996 ·Molecular Pharmacology ·Richard A. Glennon, Maƚgorzata Dukat, Richard B. Westkaemper, Abd M. Ismaiel, (unknown), Eric M. Parker	24
16	Agonist-induced desensitization and phosphorylation of human 5-HT1A receptor expressed in Sf9 insect cells 1995 ·Biochemistry ·Canan G. Nebigil, Maria N. Garnovskaya, (unknown), Janet G. Mulheron, Eric M. Parker, Thomas W. Gettys, John R. Raymond	33
17	Carboxyl-terminal Domains in the Avian β1-Adrenergic Receptor That Regulate Agonist-promoted Endocytosis 1995 ·Journal of Biological Chemistry ·Eric M. Parker, Philip M. Swigart, Mary H. Nunnally, John P. Perkins, Elliott M. Ross	28
18	Cloning and characterization of the rat 5‐HT_5Breceptor 1993 ·FEBS Letters ·William Wisden, Eric M. Parker, Cathy D. Mahle, (unknown), Henry P. Nowak, Frank D. Yocca, Christian C. Felder, Peter H. Seeburg, Mark M. Voigt	53
19	Thermodynamic analyses of the binding of substrates and uptake inhibitors on the neuronal carrier of dopamine labeled with [3H]GBR 12783 or [3H]mazindol. 1990 ·Journal of Pharmacology and Experimental Therapeutics ·J. J. Bonnet, Saloua Benmansour, Jean Costentin, Eric M. Parker, Luigi X. Cubeddu	52
20	Evidence for autoreceptor modulation of endogenous dopamine release from rabbit caudate nucleus in vitro. 1985 ·Journal of Pharmacology and Experimental Therapeutics ·Eric M. Parker, Luigi X. Cubeddu	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact